A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family.
暂无分享,去创建一个
[1] S. Avigad,et al. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies , 1997, Oncogene.
[2] V. Rotter,et al. A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility. , 1995, DNA and cell biology.
[3] C. Felix,et al. Complex replication error causes p53 mutation in a Li-Fraumeni family. , 1995, Cancer research.
[4] D. Malkin,et al. p53 and the Li-Fraumeni syndrome. , 1994, Biochimica et biophysica acta.
[5] D. Lane,et al. Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53. , 1994, British Journal of Cancer.
[6] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[7] M. Green,et al. Allelic variation of reporter gene activation by the HRAS1 minisatellite. , 1993, Genomics.
[8] J. Serth,et al. Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 gene. , 1993, Clinical chemistry.
[9] R. Reddel,et al. Germ-line splicing mutation of the p53 gene in a cancer-prone family. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[10] D. Lane,et al. Abnormal expression of wild type p53 protein in normal cells of a cancer family patient , 1992, The Lancet.
[11] S. O’Brien,et al. Detecting single base substitutions as heteroduplex polymorphisms. , 1992, Genomics.
[12] T. McDaniel,et al. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. , 1992, Cancer research.
[13] Thierry Soussi,et al. TP53 tumor suppressor gene: A model for investigating human mutagenesis , 1992, Genes, chromosomes & cancer.
[14] T. McDaniel,et al. The MspI polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products. , 1991, Nucleic acids research.
[15] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[16] J. Yokota,et al. Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinoma. , 1990, Biochemical and biophysical research communications.
[17] R. Moll,et al. Heterogeneity of intermediate filament expression in human testicular seminomas. , 1990, Differentiation; research in biological diversity.
[18] L. Strong,et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.
[19] M. Bar‐eli,et al. A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivation , 1990, British journal of haematology.
[20] J. Minna,et al. Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. , 1990, The Journal of clinical investigation.
[21] T. Sekiya,et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[22] W. Blattner,et al. A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.
[23] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[24] E. Abraham,et al. Fluorescent 2'(3')-O-aminoacylnucleosides-acceptor substrates for ribosomal peptidyltransferase+. , 1976, Nucleic acids research.
[25] A T Look,et al. Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. , 1994, Oncogene.
[26] C. Felix,et al. A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. , 1993, Oncogene.
[27] P. Guevara,et al. Rapid recovery of DNA from paraffin-embedded tissue sections for routine polymerase chain reaction analysis , 1993 .
[28] G. Thomas,et al. Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. , 1993, Oncogene.
[29] D. Parkinson,et al. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients , 1985, Nature.